ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Modular Rh-Catalyzed Synthesis and Biological Profiling of Diverse Pentafluorobenzenesulfonamide Reactive Fragments.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Covalent protein modification can facilitate the elucidation of biological mechanisms and serve as a powerful strategy for drug discovery. The discovery of protein modifiers may be initiated by screens of diverse sets of reactive fragments. A modular synthesis of diverse pentafluorobenzenesulfonamide reactive fragments was developed, which was based on the reaction between diverse, readily-available substrates and rhodium nitrenoid intermediates formed from pentafluorobenzenesulfonamide. The approach enabled the synthesis of 21 reactive fragments whose diversity stemmed from both that of the substrates and the rich chemistry of rhodium nitrenoids. The fragments were found to modify Aurora A kinase via several distinct pathways. Furthermore, five of the reactive fragments were profiled against HeLa cell lysate, which demonstrated that the constellation of modified cysteines was critically dependent on the specific reactive fragment used. Overall, the modular Rh-catalyzed connective approach enabled the synthesis of reactive fragments with high structural and reactivity diversity. We envisage that such reactive fragments may provide useful starting points for the discovery of covalent modifiers of proteins, including chemical probes and drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.